<SEC-DOCUMENT>0001575872-25-000015.txt : 20250108
<SEC-HEADER>0001575872-25-000015.hdr.sgml : 20250108
<ACCEPTANCE-DATETIME>20250108062022
ACCESSION NUMBER:		0001575872-25-000015
CONFORMED SUBMISSION TYPE:	6-K
PUBLIC DOCUMENT COUNT:		4
CONFORMED PERIOD OF REPORT:	20250107
FILED AS OF DATE:		20250108
DATE AS OF CHANGE:		20250108

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			DR REDDYS LABORATORIES LTD
		CENTRAL INDEX KEY:			0001135951
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		IRS NUMBER:				000000000
		FISCAL YEAR END:			0331

	FILING VALUES:
		FORM TYPE:		6-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-15182
		FILM NUMBER:		25516500

	BUSINESS ADDRESS:	
		STREET 1:		8-2-337, ROAD NO.3 BANJARA HILLS
		CITY:			HYDERABAD
		STATE:			K7
		ZIP:			500-034
		BUSINESS PHONE:		91 40 49002900

	MAIL ADDRESS:	
		STREET 1:		8-2-337, ROAD NO.3 BANJARA HILLS
		CITY:			HYDERABAD
		STATE:			K7
		ZIP:			500-034
</SEC-HEADER>
<DOCUMENT>
<TYPE>6-K
<SEQUENCE>1
<FILENAME>drr0710_6k.htm
<DESCRIPTION>FORM 6-K
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: right; text-indent: -0.5in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: right; text-indent: -0.5in"></P>

<!-- Field: Rule-Page --><DIV STYLE="width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 2pt solid; border-bottom: Black 1pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: right; text-indent: -0.5in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: right; text-indent: -0.5in"></P>

<P STYLE="font: bold 14pt Times New Roman, Times, Serif; margin: 0; text-align: center">SECURITIES AND EXCHANGE COMMISSION</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>Washington, D.C. 20549</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 2in; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 18pt Times New Roman, Times, Serif; margin: 0; text-align: center">Form 6-K</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE
13A-16 OR 15D-16 </B></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">UNDER THE SECURITIES EXCHANGE ACT OF 1934</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 0 135pt; text-align: center; text-indent: -135pt">January, 2025</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 135pt; text-indent: -135pt">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 0 135pt; text-align: center; text-indent: -135pt">Commission File
Number 1-15182</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: bold 24pt Times New Roman, Times, Serif; margin: 0; text-transform: uppercase; text-align: center"><FONT STYLE="text-transform: none">DR.
REDDY&rsquo;S LABORATORIES LIMITED</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">(Translation of registrant&rsquo;s name into English)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>8-2-337, Road No. 3, Banjara Hills</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>Hyderabad, Telangana 500 034, India</B></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-transform: uppercase; text-align: center">+91-40-49002900</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">(Address of principal executive office)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Indicate by check mark whether the registrant files or will file annual
reports under cover of Form 20-F or Form 40-F.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Form
20-F </FONT><FONT STYLE="font-family: Wingdings; font-size: 10pt">x</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Form
40-F </FONT><FONT STYLE="font-family: Wingdings; font-size: 10pt">&uml;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Indicate by check mark if the registrant is submitting the Form 6-K in
paper as permitted by Regulation S-T Rule 101(b)(1): ______</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0"><B>Note:</B> Regulation S-T Rule 101(b)(1) only permits the submission
in paper of a Form 6-K if submitted solely to provide an attached annual report to security holders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Indicate by check mark if the registrant is submitting the Form 6-K in
paper as permitted by Regulation S-T Rule 101(b)(7): ______</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><B>Note: </B>Regulation S-T Rule 101(b)(7) only permits
the submission in paper of a Form 6-K if submitted to furnish a report or other document that the registrant foreign private issuer must
furnish and make public under the laws of the jurisdiction in which the registrant is incorporated, domiciled or legally organized (the
registrant&rsquo;s &ldquo;home country&rdquo;), or under the rules of the home country exchange on which the registrant&rsquo;s securities
are traded, as long as the report or other document is not a press release, is not required to be and has not been distributed to the
registrant&rsquo;s security holders, and, if discussing a material event, has already been the subject of a Form 6-K submission or other
Commission filing on EDGAR.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Indicate by check mark whether by furnishing the information
contained in this Form, the registrant is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the
Securities Exchange Act of 1934.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Yes
</FONT><FONT STYLE="font-family: Wingdings; font-size: 10pt">&uml;</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">No
</FONT><FONT STYLE="font-family: Wingdings; font-size: 10pt">x</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">If &ldquo;Yes&rdquo; is marked, indicate below the file number assigned
to registrant in connection with Rule 12g3-2(b): 82-________.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<!-- Field: Rule-Page --><DIV STYLE="width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; border-bottom: Black 2pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>EXHIBITS </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="border-bottom: Black 1pt solid; text-align: center; font: 10pt Times New Roman, Times, Serif; width: 10%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit Number</B></FONT></TD>
    <TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; width: 1%">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left; font: 10pt Times New Roman, Times, Serif; width: 89%; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Description of Exhibits</B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><A HREF="drr0710_ex99-1.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-size: 10pt">99.1</FONT></A></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><A HREF="drr0710_ex99-1.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-size: 10pt">Intimation dated January 7, 2025 </FONT></A></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>


<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>SIGNATURES </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="3">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">DR. REDDY&rsquo;S LABORATORIES LIMITED</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">(Registrant)</P></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date: January 7, 2025 </FONT></TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD COLSPAN="2" STYLE="vertical-align: bottom; border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ K Randhir Singh</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%">&nbsp;</TD>
    <TD STYLE="width: 5%">&nbsp;</TD>
    <TD STYLE="width: 7%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="width: 38%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">K Randhir Singh</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Company Secretary</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>


<!-- Field: Page; Sequence: 3; Options: Last -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>drr0710_ex99-1.htm
<DESCRIPTION>EXHIBIT 99.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Exhibit 99.1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 64%; font-size: 10pt"><IMG SRC="drr0710_ex99-1img01.jpg" ALT="">&nbsp;</TD>
    <TD STYLE="width: 36%">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>Dr. Reddy&rsquo;s Laboratories Ltd.</B></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>8-2-337, Road No. 3, Banjara Hills,</B></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>Hyderabad - 500 034, Telangana,</B></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>India.</B></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>CIN : L85195TG1984PLC004507</B></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>&nbsp;</B></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>Tel&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;: +91 40 4900 2900</B></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>Fax&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;: +91 40 4900 2999</B></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>Email&nbsp; : mail@drreddys.com</B></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>www.drreddys.com</B></P></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">January 7, 2025</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">National Stock Exchange of India Ltd. (Scrip Code: DRREDDY-EQ)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">BSE Limited (Scrip Code: 500124)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">New York Stock Exchange Inc. (Stock Code: RDY)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">NSE IFSC Ltd (Stock Code: DRREDDY)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Dear Sir/Madam,</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.5in"><B>Sub:</B></TD><TD STYLE="text-align: justify"><B>Disclosure pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements)
Regulations, 2015 &ndash; Sale of step down wholly owned subsidiary of the Company.</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Pursuant to Regulation 30 of the SEBI (Listing
Obligations and Disclosure Requirements) Regulations, 2015 (&ldquo;SEBI Listing Regulations&rdquo;), as amended, we wish to inform that
Dr. Reddy&rsquo;s Laboratories Inc, USA, the wholly owned subsidiary of the Company, has entered into an agreement for sale of all the
issued and outstanding membership interests in its wholly owned subsidiary, Dr. Reddy&rsquo;s Laboratories Louisiana LLC (DRLL), along
with manufacturing facility of DRLL in Shreveport, Louisiana, USA. Consequently, Dr. Reddy&rsquo;s Laboratories Louisiana LLC will cease
to be a wholly owned subsidiary of Dr. Reddy&rsquo;s Laboratories Inc as well as step down wholly owned subsidiary of the Dr. Reddy&rsquo;s
Laboratories Limited.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The details required under Regulation 30 of the
SEBI Listing Regulations, read with SEBI/HO/CFD/CFD-PoD-1/P/CIR/2023/123 dated July 13, 2023, with respect to the above sale is given
in Annexure enclosed herewith.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">This is for your information and records.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Thanking you.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Yours faithfully,</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">For <B>Dr. Reddy&rsquo;s Laboratories Limited</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><IMG SRC="drr0710_ex99-1img02.jpg" ALT=""></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>K Randhir Singh </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Company Secretary, Compliance Officer, and Head-CSR</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Encl: as above</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt"><IMG SRC="drr0710_ex99-1img01.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Annexure</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><U>Disclosure under Part A Para A(i) of Schedule
III read with Regulation 30 of the SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><P STYLE="margin: 0"></P>

<TABLE CELLSPACING="0" CELLPADDING="4" STYLE="width: 100%; border-collapse: collapse; font-size: 10pt">
  <TR STYLE="vertical-align: top">
    <TD STYLE="border: Black 1pt solid">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Sl. </B></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>No</B></P></TD>
    <TD STYLE="border: Black 1pt solid; text-align: left; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Particulars</B></FONT></TD>
    <TD COLSPAN="3" STYLE="border-top: Black 1pt solid; text-align: left; border-right: Black 1pt solid; border-bottom: Black 1pt solid; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Description</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-left: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">1</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-left: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">The amount and percentage of the turnover or revenue or income and net worth contributed by such unit or division or undertaking or subsidiary or associate company of the listed entity during the last financial year</FONT></TD>
    <TD COLSPAN="3" STYLE="border-right: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">The details as per last audited financial statement for the financial year ended March 31, 2024 of Dr. Reddy&rsquo;s Laboratories Louisiana LLC (DRLL) are as hereunder: </FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-left: Black 1pt solid; width: 5%">&nbsp;</TD>
    <TD STYLE="border-right: Black 1pt solid; border-left: Black 1pt solid; width: 40%">&nbsp;</TD>
    <TD STYLE="border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: left; width: 17%; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif">Particulars</FONT></TD>
    <TD STYLE="border-top: Black 1pt solid; text-align: left; border-bottom: Black 1pt solid; border-right: Black 1pt solid; width: 20%; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif">Amount (USD)</FONT></TD>
    <TD STYLE="border-top: Black 1pt solid; text-align: left; border-bottom: Black 1pt solid; border-right: Black 1pt solid; width: 18%; vertical-align: bottom"><P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">% of</FONT></P>
                                                                                <P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">consolidated</FONT>&nbsp;</P>
                                                                                <P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">Income/ Net</FONT></P>
                                                                                <P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">Worth of the</FONT></P>
                                                                                <P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">Company</FONT></P></TD>
    </TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-left: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="border-right: Black 1pt solid; border-left: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">Turnover</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">USD 38.91 million <SUP>(1)</SUP></FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">0.68%<SUP>(3)</SUP></FONT></TD>
    </TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-left: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="border-right: Black 1pt solid; border-left: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="border-right: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">Net worth</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">USD 29.49 million <SUP>(2)</SUP></FONT></TD>
    <TD STYLE="border-right: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">0.47%<SUP>(3)</SUP></FONT></TD>
    </TR>
  </TABLE>

<P STYLE="margin: 0"></P>

<TABLE CELLSPACING="0" CELLPADDING="4" STYLE="width: 100%; border-collapse: collapse; font-size: 10pt">
  <TR STYLE="vertical-align: top">
    <TD STYLE="border: Black 1pt solid; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif">2</FONT></TD>
    <TD STYLE="border-top: Black 1pt solid; width: 40%; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Date on which the agreement for sale has been entered into</FONT></TD>
    <TD STYLE="border-top: Black 1pt solid; width: 55%; border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">January 6, 2025</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">3</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">The expected date of completion of sale/disposal</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">By March 18, 2025</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">4</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Consideration received from such sale/disposal</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">USD 1 </FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">5</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Brief details of buyers and whether any of the buyers belong to the promoter/promoter group/group companies. If yes, details thereof</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: justify"><P STYLE="margin-top: 0; margin-bottom: 0">Jaguar Labs Holdings, LLC, a Delaware limited liability company.</P>
                                                                                <P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>
                                                                                <P STYLE="margin-top: 0; margin-bottom: 0">Jaguar Labs Holdings, LLC does not belong to the promoter/ promoter group/ group companies.</P></TD></TR>
  <TR>
    <TD STYLE="border-right: Black 1pt solid; vertical-align: top; border-bottom: Black 1pt solid; border-left: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">6</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; vertical-align: top; border-bottom: Black 1pt solid; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Whether the transaction would fall within related party transactions? If yes, whether the same is done at &ldquo;arm&rsquo;s length&rdquo;</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">The transaction is not a related party transaction as Jaguar Labs Holdings, LLC is not a related party to the Company or any of its subsidiaries..</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">7</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Whether the sale, lease or disposal of the undertaking is outside Scheme of Arrangement? If yes, details of the same including compliance with regulation 37A of LODR Regulations</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">No</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">8</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Additionally, in case of a slump sale, indicative disclosures provided for amalgamation/merger, shall be disclosed by the listed entity with respect to such slump sale</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Not applicable</FONT></TD></TR>
  </TABLE>

<P STYLE="margin: 0"></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">(1)</TD><TD STYLE="text-align: justify">Turnover includes intercompany sales of USD 23 million. DRLL has only one manufacturing facility in Shreveport,
Louisiana, USA. This facility is non-strategic for the Company with no future pipeline of products. No products/ANDAs are being divested
as part of this transaction. Any products manufactured at the site are being tech-transferred based on commercial viability.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">(2)</TD><TD STYLE="text-align: justify">Net Worth is primarily comprised of Inventories and Inter-company receivables. These items are expected
to be utilized/realized before the closing of the deal.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">(3)</TD><TD STYLE="text-align: justify">The % are computed excluding inter-company transactions.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in">&nbsp;</P>


<!-- Field: Page; Sequence: 2; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt/107% Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt/107% Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>drr0710_ex99-1img01.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 drr0710_ex99-1img01.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1"  L +<# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#^^\D#J0/J
M0*4\'!X/H>M<?XL^(?@?P%:VU[XU\8^'?!]G>RR0V=UXBUC3-'M;N:)%DEAM
MKC4[FWBGECC97>.)V=4*NP .2GAGXD?#_P 91QOX0\;>$?$J2K(R)H?B31]7
ME<1#,A5-/O;DE8UY?!(4<G ZU&,IJ3A&4U"ZFX1E-0LDWSN$9*-DTWS.-DTW
M9--DO=2<O=3U3E[J:;:33ERIIM-)IM736Z:78T4@96Y5E(R1D$'D'!''<'@C
MJ#P>:7(P3D8&<GL-O#9/0;3P?3O4[_E]VC_'3UT#_*_R[^GGMYB9!X!&?3(H
MR ,D@#USQ7*^+O&_@_P#HI\0>.O%N@>#M!6X@M6U7Q3JNG:3IZW5SO%K;F^O
MKBWMQ/<&.000F0R2['"*VUL><Z?^TY^SKJM[;Z=I?QR^%E]J&H3+;6=I!XZ\
M/3RS7#G"6\,2:D2\[G 6)!YC-P!3A&51M4XRFU+E:A&4VI-*2BU",VI.+4E%
MI2<6I<O*TV--)2::B[VDTU%V=G9M).ST=F[/1V>A[C135=&4.K*R$ AE8%2&
MP5(8$@@@@@@X.1CJ*4LH(!903G ) )QUP.IQWQT[TNZZIV:ZI]FMT_)V?D'G
MTM>_2V][[6MUO;S%HI,@=2/N[NO\/][_ '??I[UEW^NZ'I4EE#JFLZ5ILNHR
MB#3XK_4;2SDOYBR((;)+B:-KJ4O)&HC@$CEI$7&64$ZI=6[)=6]79+=NR>B3
M>CTT=C9-O113<GTBDFVV]DDDVVVDDFVTDVM6CU]NOM]?2DR,D9&0 2,C(!S@
MD=@<'![X/I7.WGB[PMIVHQZ1J&N:58ZM.8A9Z7>:G96NHZ@9I&BA%G8S3I<W
M1ED1XXA#$_F.KHN64BA:M):N7PI:N6DI>ZE=R]V,I:)^[&4OAC*43HWT2YF^
MBC_,WLH_WFU'S.C'/3GZ45''<13 $%4!"L"2!E6)5&!X!5V!53T8\ D\4XR(
M!N+H%]2P ^Z7ZDX^XK/_ +H+= 30VENTM+ZM+1*[>K6B2;;V23;:2N'6W733
MKJ[+3?5M)::MV5WH+D>H_,4M<]H/C+PAXJ.ICPOXF\/>)#HMZ^FZP-!UO3M8
M.DZC'N,FGZF-/N;@V%[&$<O:W7E3KM;=&-IQT.0>ASU'X@X(_ \'WIV:W35U
M&2NFKQE%2C)72O&46I1>THM2BY1:DTVDVFTFFTTVDTXMQDFFTTXR3BTTFI)Q
M:4DXKG?%/BOP[X)\.ZWXO\6:YIWAWPUX?T^;5->UW6[NVLM-TFQM461Y;VZN
M)(+2TB17#F2>1%&]68@-N'\PO[3?_!QG;:'XLU+PM^RY\)=.\6^'])N+FRD^
M)'Q&O[VPMO$"VO\ R\^'?#VGH+Z*"YZ13:PD,<_WD49"K] ?\'%GQC\2>"_V
M7/AC\,O#M])I^G_%WXDRVOBF2&2XMS=Z#X1THZE%H[M;E9F@U+5[JRM;^+.T
MQ08=01BOXNZ]? 8*G.DJ]://S3E&$7\*4+:WW=^97Z*V@S^IO]GG_@XZ\2WO
MCO1M#_:2^#GAG1_ &J:C;6=WXP^'6JZM<ZMX7AN@0-3O-$OX1%JFG6F?WUG;
M.MVF!YC !<?T#_M$_M@?#GX(?LF>,/VMM(O[+Q_X*TGP9:^)O!\VBZFLFF^+
M[[6IH-,\+6%GJ,.;5%U75KJWM;H2-NMYF,#JMR56O\UVOZLO^":WPD\1_MQ?
M\$<OC]^S)>^*SHLNC_%37=(^'NKZB[&PTQM'B\%_$_1K*\D\XM!H[>)KBXLW
M!8K9Z>KE%"J5-XO"8>GR5U%4X*I&-6S6D9NR>K5M5:[T>SU#MYNR\W:]EW=D
MW97=DW:R;7YYZ1_P7G_;[LOB='XYU7Q%X&U;PFNHBZOOA+_PB%G9^%HM)VX_
ML"/5;:5]?4X/_(2_M'/_ $TS7]??PA_;.^#GQ,_90\(?M?:UXAT_X;_##Q'X
M9?Q!K.I>+]0%E!X:U"TU2?P_K.F7<Q(BNY;#Q'9'2K*.W9Y+TA8X8O-<15_%
MG#_P18_X*&R>)?[ F^#VAV>EK>/;OXWN_B!X.F\$VFG1HTDFMG4H[[S)M'1%
M+-;[S(H!)( -?L;\:_#_ .QC\5?V%/AY_P $QOA-^VO\&K?XP_#6?PS<Z9J6
MO:W>VG@/QKXYTK5M1UKQ#X?U/7DMYK![?4=;UG5)]&M#<R26\MMIPN8V!#F<
M12PE2K1H4.5UG-<].C"<IQHWM.<H.+FI)JU-<B4FIIW<6D-VIRK/^%!VE-:Q
M3[<WP775.5UV/Z%O@C^T!\%/VCO#$OC3X&_$;PQ\3O#%K=G2KW5/#%]'>+87
MT48DCM[^"ZM[6_M+B2$B1([J")GC8.B%<L"OS9_X(^_\$_\ XA_L+_"_XBVW
MQ5\3^&M8\8_%;Q%H^L?V?X+OY;_1-"T;1=*:TTY8]4GL[-;N_OH_WUV;>)D9
M-C[F&2A7D5HJ%24:3YX)M*4URRNG:2:6B:>C6C3T:35A<T6DU*+35TU*+37=
M--IK1ZIM:/70^#O^#E4H?AQ^R]:N(T>3QYXR=3)$DA,=KH^FYCB$D9#-N=21
M+D?,O ).?-/BS_P10@^&/[-VB_M'_LC_ !H^)_@[XJ^%?AQI'Q1U;1+WQ#+#
M!XB6U\.Q^(-8M-$UK2#I]QI>I10OY=E)/;26MZ-GS;Y%2N__ .#EJ8-X0_92
MC!!'_"6?$)\Y!'F#1]$(3_>*Q2G'4JCGHC$?5/[0'_!5#]C[X;?L-C0?"OQA
M\(_$/XFZY\$-'\!Z!X&\)7QU/56\1ZOX-M=$=M79+:2TTRST^7/VR:\*)"\3
M0NJEF*52GB:'#N/Q.7JI+'T^*,8Z,**4IU8TLMRUX>C.#]V6'EB6J=3G7)RN
MHV^:%H^A.,99IP_3KJ,L%5R6G]<4_P"&X3S/$*O-R=H1K1PTJDZ;YE-2C#E3
M4FWY]^R-_P %E=%T;]@JT^.'[3]MXE\1>*/A]X]TKX*^);SP=H=MJ&I>*]6O
M=.>^\/ZY-%<ZEIZ6SWMA!*+^5E ?4(YE;,PEK[)_9E_X*X?LT_M<?'/2O@5\
M';+X@ZCKVI>#-3\72:YK?AR+1]%TUM'LA/J.C33+?277]HHQVS7!C6!)!Y;,
MA.ZOY<M5^#?BKX:?\$:IO&WBS2[O1V^,O[4_A'Q'X5L[RWN;:23P[H^@7^E:
M=J4*W,49N(-3N;AY;.YA#0W(*M"[AU)_H,^ 'CO]BS_@F[^P?^S+\:?B5X5T
M'POKWC3P+X9A7Q7H'@.SUWXH^+O$7BS2CK&O)_:-E8RZS)IJVN?MLJ7PMK:%
M5:0H06E]G'4<'&KFV(K07-A\RP.70P^'?LHRS#'\.4L0Z5.*]WEACY56TKS=
M>"I)<RG"'CPIR5#+:.'C5JSQU'-<7[><N:,,#E>?XBE*3U;<5A*=&E"4;P=&
MK4J2G947*_\ \'!;'_AWY,H(+2?&?X=H=J2,#A/$#F$B&6*79@$M@X( )PM?
MB!;_ /!.C]C:3_@FQ9_M7W/QQE\+?'=?AQ=^+U\.77C+PY/I]UXIM]6U&.P\
M.VGA>%UUT75W!! ]LD$#W,T<\,D4;1/O'ZU_\%H_C)\/OC__ ,$LO"_Q:^%.
MO'Q+X&\:?%;X;WNA:D+-[26:!H_$5O<0WECJ AN+6\M9HI(+F"5$EMYU:)P&
M4D_SO?%[]C>S^"7[/?[&G[6LUOK7C7X4?&46'_"T]#:X^RQZ3KUIXG<?V%I]
M[8Q0&.P\2:%%);VLPMPHO4:&/,@P/,RG#5U0S7#UZ\\JKU^)\KP,,34C'GPF
M(Q&74Z=.,T^6"594N9MR37+%J\6F_3E4ISCDM>DOKL:>7YSC'@8-16+I83&8
M9UES/5S@G[D()R=JMXITVX_TV?\ !*[]LG3?!_\ P35\+?%[]K'XEQ>'_#_@
MOQ'XL\#Z1XY\;ZA)+J6OZ)X>O9VTRSM=S7>I^(]7L8()K2-;2*[NKMX'6-&\
MIPOU/\!/^"M'[$'[27C2#X;_  \^+(TOQMJ-\UAH&@^.='OO"<WBF;=L@3P]
M?WZOI>H/?.,64<ER)KLY2WCD? K^>G_@K(WA!=)_X)Q:)^SKX?\ "NF?LPZI
MX)36?AOH&K7DZ_#>[\1:AXC@N-0T_P 9ZE+-&)Y+.".QAU>_O92]F9M1%T\>
MR0"O^V;\ _VQ/'6O_ B+QYX"_P""=O[/-UI7B_2C\)/%WPJ^(?A/X;ZIXBO2
MOGV.DRS#7IGO=$\U=L1@:6:1O]66)Y]2I0H8W'5<3B8U,)2Q6=ULG6%J*.$Q
M6#6$HT*.(QDZ;]M&KF%:O&56.515.:4I2C7E&<)'EQHK#X##PA7ISJ5,I_M=
M5I5I3H5(XS$8BI1PD9>R@UA,/2C&C/%N492E'EE2P\X3@?U$_M,?MU_LS?L@
M:7HM]\>/B+8^%+G7YIH=&T"R@N-:U^^6W9(YKNWTC2A/>PZ=#(ZI-=2Q)!$S
MHK,&(#?S8?\ !2;]MKX!?MC?M#_L#Z_^S]X^E\5Z?X5^*5MIWBBPN=*U;0K[
M1[F]\9>'TM3J.GWML@>"[M8Y4MW@CN%G /EL^"%J_M"^&_"_Q#_X+:_#+P?^
MV7%I*?#.3PO\.H+'3]8OI+3P'>S0> ;'4+.WANKR:WL4\.ZSXU1[?5K@3@LR
M-#-*K*<5_P#@J=\)/V7_ (:_MT_L;-^SEI7PX\.:GXE\3^$)?''ACX8G2(?#
M=FUCX[TR+1-8ETCP]&=+T:^O49UC@A>*>YC0.L+C$LF&34:,<RX1Q.(4JM?%
M\0.6&A02G0A+ X[$X6E[=5?B52"A5KTYJ,*;DEI%Q;Z<742PF?T8*6'E3X4Q
M.(JNNFHSAC\F6,J0H.*2<Z*E&G&47*K&ISTY*-2,H1_I&_:?_P""@/[*_P"Q
MW<Z'IOQT^)=GX;USQ%9&_P!'\+:987WB/Q!)I,;&.+4Y[#3UE&FZ>[@1I>WH
MBMV<;4D)%?SM_M/?M5_!+]KO_@J+_P $[OB!\!_&LGB[P]!XJ\#Z'KD-Q::A
MI-WI.J)\0;\2P:KINH16MK()[*1(E2%)V<,NU2&&<MO!OPV^)'_!=GXC>%OV
MS+31[OPO#)=W'@W1_'=Q#:>#-1DMO#6G3> (V:^N8+;4--E>:YAB@D>.#5-8
MB>V033QR1A/VI?A?^SC\,O\ @LA^QQ8?LYP^"="TW7_&/PNUGQKX=^'$^F2^
M&=(\6)XLU"VMY+>+2;I;#1IY--B@NKNPLI3(MQ+&6B7>F9R:E36*X6Q-5NI7
MS:688[#QHI2HX91R_-J4,)B/;)+GA!5'54W&4*TJ-)1BZJC,S:*I8/BG"PG&
M*P60\E2K-2A'%4\1@\-B*U3"3BE4C&-2I*E0G#FJRY)<W[Q2C'^B3X-?\%"/
MV8_C;\>O'?[-_@7QA?I\6O!$VMVFJ>&==T&]T 7\GAR[:RUA-%N]0C@74&MY
M$>Y"0*2D"O*P"JPJY\7_ -M3]G'PI\9]!_9!\3^/[ZT^,OQ9T&6RT3P_X=T2
M]U&\AC\0V=]%IPOM4M8I(='U34K=3<6-O/Y<VP">)5C*R#\#/^"H?PZUO]A3
M_@H%\%?^"A?@3PUJ>I> ?%'BJVU'Q[8Z2)+&.;QC8Q)I/B'3[V[A3[)#)XI\
M/W$M[9-<ND-]J:.(DDD4UV?_  2#^'VN?ME?MK?M$_\ !1KX@V%\NBV/BG7-
M.^&5CK9;4'TO7O$?VJ.VLK>Z*-:3Q>"_!4\&BI'9/BQN)X+N01&6-FY,OP5#
M,,OPU=RE3H4<KS2>?N<E*I0S##N&$I8?#M-S3S!XNC5PKM[%TU4G&4H<DGIC
M6\NGB:E.$IJK4RNKD";C)5?K=:G6Q"KM_'_9,,/66(IS23G*G&2BU5C'!_87
M^)?PO_X)!^'_ (Z^*/VK[CXB^'/%7QW^)<S?#;X/-I-KXB^*=WX \'ZEX@AT
MKQUKVDV][8V6C+XJO=5CMEN+J_CM;Q+,>6\OE'R_W@_8]_X*#_LU?MR:=KL_
MP.\1ZI/KGAB.&?Q)X'\4Z.GA_P 5Z/9WL@@@U233S+=V][I]Q<9A2]M+^:VD
ME!C\S?@-^*O_  5G^!/B/QG^W?\ !WQ_^SK\6?@Y>_M.:;X-L4L/@%\1;OPZ
M^K7]II,FHW&G:UI.D^,].O\ PAJ-CJ,2R@:/J+QW-Q?PL(4D(XU?^",_QE\+
M:W^U5\??A?\ $+]FGP!\)OVH(M$U"Z\:>/\ X;OK.G:9K,6CZR+36=#U+PK+
MXAU7PMH-Q:WYCFL[SPA9:?92H'C"-O!';AHPS/!O$U[*M1P56E0I0J0HU*>&
MR2.'RZE.*=/DQE-TX>TQE2G756A5G&$5)7BL\SD\-)UJ=E]:QF'KU:E6"]VI
MGF)J8NK&4&E*$:+K3AA8PBHU*<.>;2<I+] O^"SO[(7BW]K7]D>[@^'.D7>M
M_$_X0>(X/B1X4T&R3_3_ !-;VUEJ&C>(_#NGND;O/?ZIH5Y>76GV%M')<7.J
MQ:;%'$TTD(?^"2_TW4=*U"]TG4["]TW5=,GFM=1TR_M9[/4-/NK=MEQ;7MG<
M1QW-I/ _R30SQQR1-\KJIXK_ %4RJD8(#AO]8KC*-]0V1D=AR/7G!K^?7_@K
M/_P2%T[]I/3]5_:!_9UT:VTKX]:9;RW?B?PC:K#:Z;\7+:W5KAIPK)%#8>.8
MG %I?JODZGD1RHUP TW'A\QEA'"%5.6%=U.I[[^JK3]\X14I5**_Y?1IQ=:$
M/WT(5(4ZE.?32A&LO9\W)57\'F<5";?Q0E*37))Z>SDVH7NIM:,_BG9E3.]E
M3:Q5MQ"X8=5.<88=P>1WK]<_AIIO[3H_X)/>(;OX)VWCT>"M2_;#\2?\+9/@
M--3_ +=O?#=I\,O!B:3+<MI$$E_/X1_M#R[+5I;#$<-WMMYY%GPE?+W[(GQP
M^'_[)_Q>\6ZQ\>_V:=#^.L$/A_5_!,_P_P#B%!:6TW@[Q"LR_P"E76D:YIVH
MVHNXBI@N5FTJ.XA#L%:&;:Z?N_\ L"_M4ZA^RS_P1\_:#^/GA3PMI]YK.C_'
MSQ;;^"O#E^TEQHMAJ?C&?P39:##?0QW"+<Z?H)U>R#.I5+DVVPLR[UKULTA&
M6 JXB+=:CA5DF8TJE&5-X;%UZN>QP=/ 5*CG=PJX>JL;S4Y2IRHU</[22O-D
M8:I6I8ZCA_JRE5Q5?$99&E5DXU%"MD^(Q4\=2LN6#H3A[./M.6I%2>D9W2^,
M-'\<_MD?#K_@C/\ %/\ X2F]^*V@^'/$'[0O@?PGX9U+Q*VM6>K)\)=7T.^N
MO$\6D7.HPP:U:^%[S7X+;3;2^=]DQEC@BG+RA7_"$ *@4-)$HD\]@<*D4NW[
M1O@:&;?YGFG:+Q9_O<!L\5^W_P"SY_P5C_:6^-_QJ\,?!?\ :RU#PQ\>?@!\
M<O$FE?#GQS\*]6\#^%M!TW3K#Q?K?]E6&L>'=5\+:?H^N6=]H]R%EC\JY!B9
M4<@,J%?W+M_^#>[]@VV\7?\ "2_:/C1+HYU/^TQX(D\<V3>&P"O_ "#BX\.?
MVZ=)W<?8_P"TA+_TTQDUM.53"8BMC<71HTJ>:5(.G7PTXU)T/[/P6$P3PM1P
MITZE.HX4Z>-:A?VD\;.=7EKNHCGA5IPI/ *<ZE?!U<5B9TG%>QKTLSQ<\51J
M45*W-"@H3P3^L*,KX9S@N2:;^HO^"1'C/QIXZ_X)\?L\:_X[O=0U/7$\/ZOI
M4.IZJ9IM2O-#TG7]0T_P[<W%Q,"]Z]QHL%I)'>9=9[<QO&[1LK$K]!?!G@_P
MUX \,:'X+\'Z+:>&O"WAK2[71]!T;1[?[/IVE:99JJ6UK;VV#AMH'F/M=RVY
MI'9R[L5X68UY8W'XS%X?_9:&(Q%2K2HRIP<HQG[/WI\CY5*;@ZDDM%*I)+1)
MOCHX>5/#X>G5OSTZ$(RY6VMZDN__ $\:UULEHKGSO^U5^Q/^SY^VCX>\->'/
MV@/"%_XHL_".J76K^'Y]*\1:QX:U'3+R[MOL=T(M2T2[TZY>&>( $$%2$4J
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MJO;>R]J^?V,J<H<]I?P>945._P#$]C"7)3Y[\J5U9MH****S&?@7_P %8_\
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GW>4N57=DDL%"/M)56KU9QA"=1_%*%/F]G%^4.>5O\3"BBBL"S__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>drr0710_ex99-1img02.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 drr0710_ex99-1img02.jpg
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M:&]P(#,N,  X0DE-! 0       \< 5H  QLE1QP"   "  ( .$))300E
M   0_.$?B<BWR7@O-&(T!UAWZ__N  Y!9&]B90!DP     '_VP"$  8$! 0%
M! 8%!08)!@4&"0L(!@8("PP*"@L*"@P0# P,# P,$ P.#Q /#@P3$Q04$Q,<
M&QL;'!\?'Q\?'Q\?'Q\!!P<'#0P-&! 0&!H5$14:'Q\?'Q\?'Q\?'Q\?'Q\?
M'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'__  !$( #4 N ,!
M$0 "$0$#$0'_Q "(   " @,! 0              ! 4& @,' 0@! 0$! 0$
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MCN**&VVJ+[7&3]W7U'07W0&@- : T%<Y'62[CA]]31=ORY5?*A,;UVCW7FC
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M;60^W#(A&(R8(($V)D6X$'J7KUQIADVQ#M]X[\<N6<HK.PQ*A.#</M'*9S&
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C="S]/3Z?;34Y<]/7@QJG(: T!H#0&@- : T!H#0&@-!__]D!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
